Early-onset autoimmunity associated with SOCS1 haploinsufficiency

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Autoimmune diseases arise from failures in self-tolerance mechanisms.
• Studying familial autoimmune diseases offers insights into common autoimmune conditions.
• The SOCS1 gene is a known regulator of cytokine signaling via the JAK-STAT pathway.

Purpose of the Study:

• To identify genetic causes of early-onset autoimmune diseases in unrelated families.
• To investigate the role of SOCS1 gene mutations in autoimmune pathogenesis.
• To understand the functional consequences of SOCS1 loss-of-function in immune cells.

Main Methods:

• Whole-exome and whole-genome sequencing to identify germline mutations.
• In vitro analysis of patient-derived lymphocytes to assess STAT activation.
• Functional assays to evaluate immune cell responses to cytokines (interferon-γ, IL-2, IL-4).
• Treatment with JAK1/JAK2 inhibitor ruxolitinib to assess pathway reversibility.

Main Results:

• Identified heterozygous, autosomal-dominant, loss-of-function mutations in the SOCS1 gene in ten patients from five families.
• Patient lymphocytes showed increased STAT activation in response to key cytokines.
• This heightened cytokine sensitivity was reversed by ruxolitinib treatment.
• Observed immune abnormalities consistent with lymphocyte hyperactivity in patients.

Conclusions:

• SOCS1 haploinsufficiency is a cause of dominantly inherited early-onset autoimmune diseases.
• Cytokine hypersensitivity in immune cells due to SOCS1 deficiency underlies the autoimmune predisposition.
• This finding elucidates a critical pathway involved in autoimmune disease development.